Caption Management’s Legend Biotech LEGN Stock Holding History

Caption Management’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$280K	Buy	+15,500	New	+$295K	﹤0.01%	1303
2025 Q4	–	Sell	-5,000	Closed	-$143K	–	1868
2025 Q3	$163K	Buy	+5,000	New	+$185K	﹤0.01%	1495
2025 Q1	–	Sell	-42,575	Closed	-$1.39M	–	1815
2024 Q4	$1.39M	Buy	+42,575	New	+$1.76M	0.01%	821
2024 Q1	–	Sell	-275	Closed	-$16.6K	–	1459
2023 Q4	$16.5K	Buy	+275	New	+$17.4K	﹤0.01%	1261
2023 Q1	–	Sell	-50,500	Closed	-$2.47M	–	1327
2022 Q4	$2.52M	Buy	50,500 +49,290	+4,074%	+$2.39M	0.04%	497
2022 Q3	$49K	Buy	+1,210	New	+$56.8K	﹤0.01%	1388

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FBIL

First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Caption Management's LEGN Position: Q1 2026 in Review

Caption Management opened a new position in Legend Biotech (LEGN) in Q1 2026: 15,500 shares worth $280K. The stake represents ﹤0.01% of the portfolio and ranks #1303 among its holdings. This is a return to the name: Caption Management previously reported a position in LEGN as recently as Q3 2025.

Caption Management first reported a position in LEGN in Q3 2022 and has held it in 6 quarters since. The position peaked at $2.52M in Q4 2022. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

Caption Management held 15,500 shares of Legend Biotech worth $280K as of Q1 2026.
Legend Biotech was a new Caption Management position in Q1 2026.
Legend Biotech made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1303 holding.
Caption Management first reported a position in Legend Biotech in Q3 2022 and has held it in 6 quarters since.
Caption Management's Legend Biotech position peaked at $2.52M in Q4 2022.
189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.